Related Experiment Video
Updated: Jun 16, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Siphonaxanthin inhibits the growth of breast cancer cell subtypes by modulating the expression of cellular proteins
Yogendra Prasad Kavalappa1,2, Nimish Mol Stephen3, Kirubakaran Baskaran Jayalakshmi4
1Department of Molecular Nutrition, CSIR-Central Food Technological Research Institute (CFTRI), Mysuru, 570 020, India.
Abstract:
The marine green algae, Codium species, have a long-standing history of use in Japanese and Korean food culture. Recent reports reveal that extracts/isolated compounds of Codium species exhibited immunostimulatory, anti-obese, and anticancer effects. This study aimed to delineate the molecular mechanism underlying the growth inhibitory effect of siphonaxanthin (SPX) isolated from Coduim sp. in luminal (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells. The cell viability was measured by WST-1 assay. The protein expression of the markers of antioxidant defense, cell survival, and apoptosis signaling pathways was analyzed by western blotting. The apoptosis induction by carotenoids was visualized using DAPI staining. The results showed that purified SPX inhibited the viability of MCF-7 and MDA-MB-231 cells at a concentration of 5 μM. The growth inhibitory effect of SPX was associated with suppressed protein expression of antioxidant enzyme, SOD-2, and its transcription factor, Nrf2. Carotenoid treatment subsequently blocked the expression of intracellular cell survival markers such as pAkt and pERK1/2, and a redox-sensitive transcription factor NF-kB. Further, suppression of antioxidant defence and cell survival markers was linked with apoptosis induction, with downregulated expression of Bcl-2, p-Bad, and PARP. Collectively, our results highlight a significant cancer chemopreventive role of marine carotenoid SPX in human breast cancer cells and demonstrate that it activates cell death partly through the modulation of antioxidant defense response-linked cell survival signaling markers.
Insights
Marine carotenoid siphonaxanthin (SPX) from Codium species inhibits breast cancer cell growth by suppressing antioxidant and survival pathways, promoting apoptosis. This highlights SPX
Area of Science:
- Marine natural products
- Cancer biology
- Molecular pharmacology
Background:
- Codium species are edible marine algae with reported health benefits.
- Marine compounds, including carotenoids, show potential anticancer properties.
- The molecular mechanisms of Codium-derived compounds in cancer are not fully understood.
Purpose of the Study:
- To investigate the molecular mechanisms of siphonaxanthin (SPX) from Codium sp. in inhibiting breast cancer cell growth.
- To analyze the effects of SPX on cell viability, antioxidant defense, cell survival, and apoptosis signaling pathways.
Main Methods:
- Cell viability was assessed using the WST-1 assay.
- Protein expression of key signaling molecules was analyzed via western blotting.
- Apoptosis induction was visualized using DAPI staining.
Main Results:
- Siphonaxanthin (SPX) significantly inhibited the viability of MCF-7 and MDA-MB-231 breast cancer cells at 5 μM.
- SPX suppressed the protein expression of SOD-2, Nrf2, pAkt, pERK1/2, and NF-kB.
- SPX treatment led to apoptosis induction, evidenced by downregulated Bcl-2, p-Bad, and PARP expression.
Conclusions:
- Siphonaxanthin (SPX) exhibits a significant cancer chemopreventive role in human breast cancer cells.
- SPX activates cell death pathways by modulating antioxidant defense and cell survival signaling.
- Marine carotenoids like SPX represent potential therapeutic agents for breast cancer treatment.
More Related Videos
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
08:30Mammary Epithelial and Endothelial Cell Spheroids as a Potential Functional In vitro Model for Breast Cancer Research
Published on: July 12, 2021
Related Concept Videos
Inhibition of Cdk Activity
Targeted Cancer Therapies
There are several types of targeted therapies against...